Image may be NSFW.
Clik here to view.
Senseonics (NYSE:SENS) said this week that won coverage from health plan provider Aetna for its Eversense continuous glucose monitoring system.
Aetna provides coverage for roughly 22 million people in the U.S., according to Senseonics, making it the third largest commercial health plan provider in the country.
Get the full story at our sister site, Drug Delivery Business News.
The post Senseonics wins coverage from Aetna for Eversense glucose monitor appeared first on MassDevice.
